156 related articles for article (PubMed ID: 28992617)
1. Iodine Promotes Tumorigenesis of Thyroid Cancer by Suppressing Mir-422a and Up-Regulating MAPK1.
Wang J; Yang H; Si Y; Hu D; Yu Y; Zhang Y; Gao M; Zhang H
Cell Physiol Biochem; 2017; 43(4):1325-1336. PubMed ID: 28992617
[TBL] [Abstract][Full Text] [Related]
2. CircRNA casein kinase 1 gamma 1 (circ-CSNK1G1) plays carcinogenic effects in thyroid cancer by acting as miR-149-5p sponge and relieving the suppression of miR-149-5p on mitogen-activated protein kinase 1 (MAPK1).
Chen H; Li Q; Yi R; Li B; Xiong D; Peng H
J Clin Lab Anal; 2022 Feb; 36(2):e24188. PubMed ID: 35023214
[TBL] [Abstract][Full Text] [Related]
3. Suppression of MIR31HG affects the functional properties of thyroid cancer cells depending on the miR-761/MAPK1 axis.
Peng S; Chen L; Yuan Z; Duan S
BMC Endocr Disord; 2022 Apr; 22(1):107. PubMed ID: 35443670
[TBL] [Abstract][Full Text] [Related]
4. Double-negative feedback loop between microRNA-422a and forkhead box (FOX)G1/Q1/E1 regulates hepatocellular carcinoma tumor growth and metastasis.
Zhang J; Yang Y; Yang T; Yuan S; Wang R; Pan Z; Yang Y; Huang G; Gu F; Jiang B; Lin C; Zhou W
Hepatology; 2015 Feb; 61(2):561-73. PubMed ID: 25251503
[TBL] [Abstract][Full Text] [Related]
5. miR-142-3p down-regulation contributes to thyroid follicular tumorigenesis by targeting ASH1L and MLL1.
Colamaio M; Puca F; Ragozzino E; Gemei M; Decaussin-Petrucci M; Aiello C; Bastos AU; Federico A; Chiappetta G; Del Vecchio L; Torregrossa L; Battista S; Fusco A
J Clin Endocrinol Metab; 2015 Jan; 100(1):E59-69. PubMed ID: 25238203
[TBL] [Abstract][Full Text] [Related]
6. miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and ERBB4.
Nie FR; Li QX; Wei HF; Ma Y
Neoplasma; 2020 May; 67(3):604-613. PubMed ID: 32266816
[TBL] [Abstract][Full Text] [Related]
7. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma.
Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M
Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050
[TBL] [Abstract][Full Text] [Related]
8. miRNA-106a directly targeting RARB associates with the expression of Na(+)/I(-) symporter in thyroid cancer by regulating MAPK signaling pathway.
Shen CT; Qiu ZL; Song HJ; Wei WJ; Luo QY
J Exp Clin Cancer Res; 2016 Jun; 35(1):101. PubMed ID: 27342319
[TBL] [Abstract][Full Text] [Related]
9. MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo.
Chen QG; Zhou W; Han T; Du SQ; Li ZH; Zhang Z; Shan GY; Kong CZ
Tumour Biol; 2016 Feb; 37(2):2095-103. PubMed ID: 26346167
[TBL] [Abstract][Full Text] [Related]
10. miR-422a inhibits cell proliferation in colorectal cancer by targeting AKT1 and MAPK1.
Wei WT; Nian XX; Wang SY; Jiao HL; Wang YX; Xiao ZY; Yang RW; Ding YQ; Ye YP; Liao WT
Cancer Cell Int; 2017; 17():91. PubMed ID: 29118671
[TBL] [Abstract][Full Text] [Related]
11. Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1.
Xu M; Zhou K; Wu Y; Wang L; Lu S
Mol Carcinog; 2019 Apr; 58(4):577-587. PubMed ID: 30556928
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-181a suppresses salivary adenoid cystic carcinoma metastasis by targeting MAPK-Snai2 pathway.
He Q; Zhou X; Li S; Jin Y; Chen Z; Chen D; Cai Y; Liu Z; Zhao T; Wang A
Biochim Biophys Acta; 2013 Nov; 1830(11):5258-66. PubMed ID: 23911747
[TBL] [Abstract][Full Text] [Related]
13. MiR-19b-3p Regulates MAPK1 Expression in Embryonic Fibroblasts from the Great Tit (Parus Major) Under Hypoxic Conditions.
Chen X; Qu Y; Cheng Y; Wang J; Lei X; Song G; Zhang H; Wang H; Lei F
Cell Physiol Biochem; 2018; 46(2):546-560. PubMed ID: 29617681
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2.
Esposito F; Tornincasa M; Pallante P; Federico A; Borbone E; Pierantoni GM; Fusco A
J Clin Endocrinol Metab; 2012 May; 97(5):E710-8. PubMed ID: 22399519
[TBL] [Abstract][Full Text] [Related]
17. Med19 is targeted by miR-101-3p/miR-422a and promotes breast cancer progression by regulating the EGFR/MEK/ERK signaling pathway.
Zhang X; Gao D; Fang K; Guo Z; Li L
Cancer Lett; 2019 Mar; 444():105-115. PubMed ID: 30583076
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-585 suppresses tumor proliferation and migration in gastric cancer by directly targeting MAPK1.
Hu L; Wu H; Wan X; Liu L; He Y; Zhu L; Liu S; Yao H; Zhu Z
Biochem Biophys Res Commun; 2018 Apr; 499(1):52-58. PubMed ID: 29550487
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2).
Geng X; Sun Y; Fu J; Cao L; Li Y
Bioengineered; 2021 Dec; 12(1):2713-2722. PubMed ID: 34130587
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
